Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03631784
Brief Title: A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799). (KEYNOTE-799)

First Submitted : August 13, 2018
First Submitted that Met QC Criteria : August 13, 2018
First Posted : August 15, 2018

Last Update Submitted that Met QC Criteria : May 22, 2019
Last Update Posted : May 23, 2019